ArticleNPJ systems biology and applications2025

QSP modeling of loncastuximab tesirine with T-cell-dependent bispecific antibodies guides dose-regimen strategy.

Yuezhe Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.